Gene · 3384
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study. | Front Endocrinol (Lausanne) | 2022 | 36187128 | PubTator, text mining | PubMed |
| The regulatory roles of T helper cells in distinct extracellular matrix characterization in breast cancer. | Front Immunol | 2022 | 36159822 | PubTator, text mining | PubMed |
| Effects of glucocorticoids on leukocytes: Genomic and non-genomic mechanisms. | World J Clin Cases | 2022 | 36158016 | PubTator, text mining | PubMed |
| Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients. | Biologicals | 2022 | 36153188 | PubTator, text mining | PubMed |
| β2-Integrin Adhesive Bond Tension under Shear Stress Modulates Cytosolic Calcium Flux and Neutrophil Inflammatory Response. | Cells | 2022 | 36139397 | PubTator, text mining | PubMed |
| Polycomb Directed Cell Fate Decisions in Development and Cancer. | Epigenomes | 2022 | 36135315 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Sickle Cell Disease: A Promising Tool. | Bioengineering (Basel) | 2022 | 36134985 | PubTator, text mining | PubMed |
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways. | Front Immunol | 2022 | 36131935 | PubTator, text mining | PubMed |
| Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. | Nat Commun | 2022 | 36127427 | PubTator, text mining | PubMed |
| Genomic mapping of copy number variations influencing immune response in breast cancer. | Front Oncol | 2022 | 36119512 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPARγ during hyperlipidemia. | Nat Commun | 2022 | 36115863 | PubTator, text mining | PubMed |
| The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? | J Exp Clin Cancer Res | 2022 | 36114508 | PubTator, text mining | PubMed |
| Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease. | Oxid Med Cell Longev | 2022 | 36092161 | PubTator, text mining | PubMed |
| Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia. | Stem Cell Res Ther | 2022 | 36068595 | PubTator, text mining | PubMed |
| Mechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity. | Allergy | 2022 | 36067034 | PubTator, text mining | PubMed |
| Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells. | Stem Cell Res Ther | 2022 | 36064647 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| Peritoneal resident macrophages in tumor metastasis and immunotherapy. | Front Cell Dev Biol | 2022 | 36035994 | PubTator, text mining | PubMed |
| Migration and homeostasis of regulatory T cells in rheumatoid arthritis. | Front Immunol | 2022 | 36016949 | PubTator, text mining | PubMed |
| Interaction between Mesenchymal Stem Cells and the Immune System in Rheumatoid Arthritis. | Pharmaceuticals (Basel) | 2022 | 36015088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3384/papers?page=16